A Democratic bill with no cosponsors
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S259-260)
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Dietary Supplement Listing Act of 2026 aims to increase transparency regarding dietary supplements. It amends the Federal Food, Drug, and Cosmetic Act to require manufacturers, packers, or distributors to list their products with the Secretary. This listing must include details such as ingredients, labels, and contact information. The Secretary will establish a publicly searchable electronic database to house this information. The bill sets specific timelines for listing existing products and new products. Finally, it authorizes funding to support these new regulatory activities.
Yes· 3 of 4
- Scored +5
Does this give people more protection from unfair business practices?
The bill enhances consumer protection by requiring manufacturers to provide detailed ingredient lists and allergen statements in a public database.
- Scored +3
Does this make health care easier to get in general?
Increased transparency regarding dietary supplement ingredients can help consumers make safer and more informed health decisions.
- Scored +2
Would households on low incomes be better off under this?
Improved access to product information can help lower-income consumers avoid spending money on unsafe or ineffective supplements.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency: The bill requires manufacturers to submit detailed information, including ingredients, brand names, and directions for use, which helps clarify what is in a product (Section 2(a)(1)).
-
Public Access to Information: The Secretary must establish and maintain a publicly available, searchable electronic database containing dietary supplement information (Section 2(a)(3)(2)).
-
Improved Safety Information: The required listings must include allergen statements for major food allergens and warnings, notice, or safe handling statements (Section 2(a)(1)(H-J)).
-
Clearer Ingredient Details: Manufacturers must list the amount per serving of each dietary ingredient, which can provide better clarity for consumers (Section 2(a)(1)(F)).
Potential Negative Impacts for People
-
Protection of Proprietary Information: While the database is public, the specific amount of dietary ingredients within a proprietary blend remains confidential and is not subject to public disclosure (Section 2(a)(1)(F)(iv)).
-
Limited Disclosure: Certain sensitive information, such as the name and address of the responsible person or the details regarding ingredient sourcing, is withheld from the public database (Section 2(a)(3)(2)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Economy And Finance
- Does this give people more protection from unfair business practices? — The bill enhances consumer protection by requiring manufacturers to provide detailed ingredient lists and allergen statements in a public database.
- Healthcare
- Does this make health care easier to get in general? — Increased transparency regarding dietary supplement ingredients can help consumers make safer and more informed health decisions.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — Improved access to product information can help lower-income consumers avoid spending money on unsafe or ineffective supplements.
- Social Issues And Justice
- Is this likely to lift people out of poverty? — While primarily a transparency measure, better information on supplement ingredients may prevent costs associated with adverse health reactions.
- 1/15/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S259-260)
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.